Search results for Bortezomib (PS-341)

260 hits were found for Bortezomib (PS-341)

# Family MCID Name MIFTS Score
1
MYL069 Myeloma, Multiple 85 1.003
2
PLS009 Plasma Cell Neoplasm 51 0.607
3
DWN001 Down Syndrome 70 0.513
4
P LYM118 Lymphoma 68 0.485
5
LYM019 Lymphosarcoma 47 0.444
6
MNT001 Mantle Cell Lymphoma 66 0.410
7
P NRP001 Neuropathy 56 0.395
8
P PRP019 Peripheral Nervous System Disease 57 0.379
9
P LKM002 Leukemia 66 0.351
10
LYM133 Lymphoma, Hodgkin, Classic 69 0.334
11
P BCL017 B-Cell Lymphoma 58 0.303
12
P LYM031 Lymphocytic Leukemia 55 0.298
13
LYM143 Lymphoma, Non-Hodgkin, Familial 72 0.271
14
P NTR004 Neutropenia 63 0.268
15
P MYL006 Myeloid Leukemia 60 0.266
16
P LNG032 Lung Cancer 97 0.263
17
P FLL037 Follicular Lymphoma 66 0.261
18
MCR004 Macroglobulinemia 50 0.254
19
P THR014 Thrombocytopenia 68 0.252
20
c LKM061 Leukemia, Acute Myeloid 83 0.242
21
LYM012 Lymphoplasmacytic Lymphoma 61 0.239
22
FCT007 Factor Vii Deficiency 66 0.237
23
c LKM071 Leukemia, Chronic Lymphocytic 79 0.236
24
P LKM062 Leukemia, Acute Lymphoblastic 68 0.234
25
c SML038 Small Cell Cancer of the Lung 65 0.232
26
c FLL041 Follicular Lymphoma 1 49 0.229
27
PPL061 Papular Epidermal Nevi with Skyline Basal Cell Layers Syndrome 25 0.228
28
P AMY004 Amyloidosis 70 0.221
29
DFF005 Diffuse Large B-Cell Lymphoma 56 0.221
30
LYM040 Lymphoblastic Lymphoma 54 0.219
31
PLS011 Plasmacytoma 56 0.217
32
LNG031 Lung Benign Neoplasm 50 0.216
33
c RHB024 Rhabdomyosarcoma 2 65 0.207
34
c PRM038 Primary Agammaglobulinemia 43 0.200
35
c ALM001 Al Amyloidosis 50 0.198
36
P ADN016 Adenocarcinoma 64 0.188
37
SNS003 Sensory Peripheral Neuropathy 53 0.188
38
MRG003 Marginal Zone B-Cell Lymphoma 53 0.188
39
ACT113 Acute Myeloblastic Leukemia with Maturation 46 0.186
40
HMT002 Hematologic Cancer 62 0.186
41
MYL009 Myelodysplastic Syndrome 70 0.183
42
LYM129 Lymphoma, Mucosa-Associated Lymphoid Type 64 0.183
43
c CHR064 Chronic Monocytic Leukemia 34 0.183
44
P CLR023 Colorectal Cancer 98 0.181
45
P PRS040 Prostate Cancer 97 0.179
46
ADL002 Adult Syndrome 69 0.176
47
P PRC017 Precursor Lymphoblastic Lymphoma/leukemia 35 0.175
48
P TCL004 T-Cell Leukemia 47 0.175
49
c LKM063 Leukemia, Chronic Myeloid 71 0.171
50
PLS025 Plasmablastic Lymphoma 47 0.169
51
P DRR001 Diarrhea 57 0.169
52
c ADL017 Adult T-Cell Leukemia 57 0.165
53
P PNC035 Pancreatic Cancer 84 0.164
54
c LKM056 Leukemia, Chronic Lymphocytic 2 48 0.159
55
RTC005 Reticulosarcoma 49 0.156
56
SQM013 Squamous Cell Carcinoma, Head and Neck 80 0.155
57
P BRS047 Breast Cancer 96 0.155
58
BRK010 Burkitt Lymphoma 67 0.155
59
c LKM060 Leukemia, Acute Lymphoblastic 3 56 0.155
60
P LYM033 Lymphoproliferative Syndrome 60 0.154
61
SQM006 Squamous Cell Carcinoma 60 0.152
62
GLB015 Glioblastoma Multiforme 75 0.151
63
P OVR042 Ovarian Cancer 89 0.148
64
c ACT073 Acute Leukemia 58 0.148
65
PLS016 Plasma Cell Leukemia 46 0.148
66
P KDN017 Kidney Cancer 61 0.147
67
LYM027 Lymphopenia 57 0.147
68
ANG046 Angioimmunoblastic T-Cell Lymphoma 52 0.146
69
MLN008 Melanoma 69 0.145
70
P KDN018 Kidney Disease 70 0.142
71
TCL023 T-Cell Lymphoma, Subcutaneous Panniculitis-Like 50 0.140
72
MYC006 Mycosis Fungoides 66 0.139
73
c ATM082 Autoimmune Lymphoproliferative Syndrome, Type V 53 0.139
74
P BND020 Bone Disease 59 0.139
75
CNS004 Constipation 57 0.139
76
SYS070 Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood 26 0.137
77
P EXN002 Exanthem 57 0.137
78
c PRS136 Prostate Cancer, Hereditary, 6 33 0.137
79
c PRS130 Prostate Cancer, Hereditary, 8 32 0.137
80
LYM048 Lymphoma, Large-Cell, Immunoblastic 29 0.136
81
P CTN015 Cutaneous T Cell Lymphoma 49 0.131
82
RNL114 Renal Cell Carcinoma, Nonpapillary 78 0.130
83
DFC004 Deficiency Anemia 75 0.128
84
SZR001 Sezary's Disease 60 0.128
85
NDL020 Nodal Marginal Zone B-Cell Lymphoma 34 0.128
86
P HPT023 Hepatocellular Carcinoma 100 0.127
87
SKN019 Skin Melanoma 67 0.127
88
P TRN020 Turner Syndrome 65 0.127
89
HDG002 Hodgkin's Lymphoma, Lymphocytic-Histiocytic Predominance 42 0.125
90
SPL004 Splenic Marginal Zone Lymphoma 51 0.123
91
TXC002 Toxic Encephalopathy 52 0.121
92
P SRC025 Sarcoidosis 1 70 0.120
93
SVR004 Severe Combined Immunodeficiency 73 0.120
94
CMR002 Coumarin Resistance 56 0.119
95
P BCL004 B-Cell Non-Hodgkin Lymphoma 44 0.118
96
HDG004 Hodgkin's Granuloma 26 0.118
97
HDG006 Hodgkin's Paragranuloma 24 0.118
98
P NRB001 Neuroblastoma 71 0.117
99
P ANP001 Anaplastic Large Cell Lymphoma 61 0.116
100
SRC014 Sarcoma 65 0.113
101
SFT003 Soft Tissue Sarcoma 56 0.113
102
SPN035 Spindle Cell Sarcoma 51 0.113
104
P GLM040 Glioma Susceptibility 1 81 0.110
105
ERY051 Erythroleukemia, Familial 56 0.110
106
c LKM070 Leukemia, Acute Monocytic 53 0.110
107
MNC006 Monoclonal Gammopathy of Uncertain Significance 48 0.109
108
OVR094 Ovarian Epithelial Cancer 38 0.107
109
OBS525 Obsolete: Squamous Cell Carcinoma of Head and Neck 57 0.107
110
ILS001 Ileus 51 0.105
111
MGK001 Megakaryocytic Leukemia 64 0.105
112
ACT193 Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22) 55 0.105
113
LYM051 Lymphomatoid Granulomatosis 45 0.105
114
c TCL024 T-Cell Non-Hodgkin Lymphoma 34 0.105
115
MLG164 Malignant Epithelial Tumor of Ovary 26 0.105
116
HYP266 Hypoxia 56 0.103
117
c MLG074 Malignant Mesenchymoma 39 0.103
118
P GST053 Gastric Cancer 83 0.102
119
P BLD134 Bladder Cancer 78 0.102
120
c CNT033 Central Nervous System Cancer 46 0.102
121
c OVR114 Ovarian Cancer 1 38 0.102
122
ACT119 Acute Promyelocytic Leukemia 63 0.101
123
BNM001 Bone Marrow Cancer 43 0.101
124
CRV035 Cervical Cancer 76 0.099
125
LTH001 Lethal Midline Granuloma 43 0.099
126
ALL026 Allergic Hypersensitivity Disease 64 0.098
127
P NRV006 Nervous System Cancer 48 0.097
128
KPS004 Kaposi Sarcoma 75 0.096
129
INT054 Intraocular Lymphoma 48 0.095
130
GST012 Gastroesophageal Junction Adenocarcinoma 43 0.095
131
P CHR285 Chronic Myelomonocytic Leukemia 59 0.094
132
PDG002 Pdgfrb-Associated Chronic Eosinophilic Leukemia 27 0.094
133
P NSP012 Nasopharyngeal Carcinoma 67 0.094
134
P HYP098 Hypereosinophilic Syndrome 66 0.094
135
EXT010 Extramedullary Plasmacytoma 45 0.094
136
MYL005 Myelofibrosis 67 0.091
137
FLL027 Fallopian Tube Carcinoma 67 0.091
138
TRN018 Transitional Cell Carcinoma 56 0.091
139
HRY003 Hairy Cell Leukemia 55 0.088
140
P CNT005 Central Nervous System Lymphoma 53 0.088
141
P RCT021 Rectum Cancer 53 0.088
142
c PRM226 Primary Central Nervous System Lymphoma 47 0.088
143
c LRG017 Large Intestine Cancer 47 0.088
144
MYL031 Myeloproliferative Neoplasm 65 0.086
145
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 57 0.086
146
P LNG064 Lung Cancer Susceptibility 3 77 0.085
147
GST040 Gastric Adenocarcinoma 70 0.085
148
c MLG054 Malignant Histiocytosis 50 0.083
149
TCL002 T-Cell Large Granular Lymphocyte Leukemia 49 0.083
150
SHR059 Short Stature, Onychodysplasia, Facial Dysmorphism, and Hypotrichosis 47 0.082
151
BRN028 Brain Cancer 73 0.081
152
P LRY044 Larynx Cancer 54 0.081
153
RFR002 Refractory Hairy Cell Leukemia 32 0.081
154
CLS052 Classic Hairy Cell Leukemia 27 0.081
155
HMN044 Human Immunodeficiency Virus Type 1 71 0.080
156
OST159 Osteogenic Sarcoma 66 0.080
157
ACQ007 Acquired Immunodeficiency Syndrome 60 0.080
158
GLS001 Gliosarcoma 54 0.080
159
PNC129 Pancreatic Adenocarcinoma 67 0.079
160
MST024 Mastocytosis, Cutaneous 67 0.078
161
c ACT027 Acute Pancreatitis 59 0.077
162
PRT058 Pure Autonomic Failure 59 0.077
163
c PCH010 Pachyonychia Congenita 3 43 0.077
164
GST071 Gastrointestinal Carcinoma 45 0.076
165
RFR004 Refractory Hematologic Cancer 30 0.076
166
RFR010 Refractory Anemia 48 0.076
167
LRG008 Large Granular Lymphocyte Leukemia 41 0.076
168
ACT177 Acute Basophilic Leukemia 34 0.076
169
GRM010 Germ Cells Tumors 34 0.076
170
END057 Endometrial Cancer 74 0.074
171
CHL065 Cholangiocarcinoma 67 0.074
172
ORL011 Oral Cancer 60 0.074
173
INT079 Intrahepatic Cholangiocarcinoma 50 0.074
174
ATN004 Autonomic Neuropathy 44 0.074
175
ESP021 Esophageal Cancer 90 0.072
176
LYM138 Lymphoblastic Leukemia, Acute, with Lymphomatous Features 49 0.072
177
URT051 Ureter, Cancer of 45 0.072
178
TRN058 Transitional Cell Cancer of the Renal Pelvis and Ureter 12 0.072
179
GST019 Gastrointestinal Stromal Tumor 76 0.071
180
EWN003 Ewing Sarcoma 68 0.071
181
BRN015 Bronchiolo-Alveolar Adenocarcinoma 54 0.071
182
GNT002 Giant Cell Glioblastoma 52 0.071
183
STM007 Stomatitis 49 0.071
184
SYN036 Syncope 45 0.071
185
ADN011 Adenoid Cystic Carcinoma 70 0.068
186
c WLM018 Wilms Tumor 5 62 0.068
187
ACT200 Acute Monoblastic Leukemia 55 0.068
188
SPP010 Suppressor of Tumorigenicity 3 51 0.068
189
P HMN032 Human Herpesvirus 8 46 0.068
190
END081 Endosteal Hyperostosis, Autosomal Dominant 59 0.068
191
GST049 Gastrointestinal System Cancer 49 0.068
192
PRT035 Peritoneum Cancer 44 0.068
193
OVR112 Ovarian Germ Cell Cancer 43 0.068
194
P MSC005 Muscular Dystrophy 66 0.064
195
c WLM013 Wilms Tumor 1 65 0.064
196
P RHB003 Rhabdomyosarcoma 62 0.064
197
SRS001 Serous Cystadenocarcinoma 52 0.064
198
CYS014 Cystadenocarcinoma 51 0.064
199
APP009 Appendix Adenocarcinoma 44 0.064
200
c WLM011 Wilms Tumor 6 37 0.064
201
URT035 Urethral Benign Neoplasm 37 0.064
202
P BCL013 B-Cell Adult Acute Lymphocytic Leukemia 32 0.064
203
c SYS004 Systemic Mastocytosis 63 0.062
204
P MST009 Mastocytosis 63 0.062
205
TNG003 Tongue Cancer 55 0.062
206
VRR004 Verrucous Carcinoma 49 0.062
207
LRY017 Laryngeal Disease 42 0.062
208
P PRN020 Paranasal Sinus Cancer 41 0.062
209
P PLM037 Pulmonary Hypertension 68 0.061
210
INS001 Insulinoma 60 0.061
211
ISL001 Islet Cell Tumor 56 0.061
212
GLL018 Gallbladder Cancer 56 0.061
213
CRC006 Carcinoid Syndrome 55 0.061
214
SMT003 Somatostatinoma 51 0.061
215
c CHR418 Chronic Leukemia 50 0.061
216
CRC014 Carcinoid Tumors, Intestinal 48 0.061
217
GLC036 Glucagonoma 45 0.061
218
MYL074 Myelodysplastic Syndrome with Excess Blasts 38 0.061
219
c ADL096 Adult Hepatocellular Carcinoma 35 0.061
220
P MLN066 Melanoma, Cutaneous Malignant 1 70 0.056
221
ALC007 Alcohol Dependence 66 0.056
222
P BLD062 Bile Duct Cancer 65 0.056
223
P MYP004 Myopathy 64 0.056
224
CLN015 Colon Adenocarcinoma 63 0.056
225
PRM126 Primary Peritoneal Carcinoma 62 0.056
226
ADN018 Adenoma 58 0.056
227
NRN004 Neuroendocrine Tumor 55 0.056
228
EPT010 Epithelial-Myoepithelial Carcinoma 53 0.056
229
CLR003 Clear Cell Adenocarcinoma 50 0.056
230
MCN001 Mucinous Adenocarcinoma 50 0.056
231
c HMN021 Human T-Cell Leukemia Virus Type 1 48 0.056
232
P PHR004 Pharynx Cancer 44 0.056
233
GLL017 Gallbladder Adenocarcinoma 43 0.056
234
MCN008 Mucinous Cystadenocarcinoma 40 0.056
235
P OVR010 Ovarian Brenner Tumor 35 0.056
236
FLL022 Fallopian Tube Clear Cell Adenocarcinoma 24 0.056
237
c PLM164 Pulmonary Hypertension, Primary, 1 75 0.055
238
ATY042 Atypical Chronic Myeloid Leukemia 49 0.055
239
P MST002 Mast-Cell Leukemia 48 0.055
240
P LVR013 Liver Disease 68 0.051
241
BRR014 Barrett Esophagus 64 0.051
242
BLD131 Bladder Urothelial Carcinoma 61 0.051
243
VLV032 Vulva Cancer 59 0.051
244
VGN017 Vaginal Cancer 55 0.051
245
HYP005 Hypokalemia 55 0.051
246
ZLL002 Zollinger-Ellison Syndrome 55 0.051
247
SRT004 Serotonin Syndrome 46 0.051
248
RCT020 Rectum Adenocarcinoma 46 0.051
249
GST030 Gastrinoma 45 0.051
250
PPL001 Papillary Adenoma 45 0.051
251
INT253 Intestinal Benign Neoplasm 44 0.051
252
c PST022 Posterior Uveal Melanoma 41 0.051
253
SML008 Small Intestine Lymphoma 35 0.051
254
EXT027 Extrahepatic Bile Duct Adenocarcinoma 33 0.051
255
RFR007 Refractory Anemia with Excess Blasts in Transformation 27 0.051
256
URT028 Ureter Transitional Cell Carcinoma 26 0.051
257
MSC157 Muscular Dystrophy, Duchenne Type 71 0.044
258
P ESS003 Essential Thrombocythemia 67 0.044
259
HYP056 Hypoglycemia 66 0.044
260
HYP346 Hypotrichosis and Recurrent Skin Vesicles 29 0.044
Content
Loading form....